Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567619-20-011355
Filing Date
2020-05-29
Accepted
2020-05-29 16:35:01
Documents
1
Period of Report
2020-05-20

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 3331
  Complete submission text file 0001567619-20-011355.txt   4873
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005 6502389600
Innoviva, Inc. (Issuer) CIK: 0001080014 (see all company filings)

EIN.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1350 OLD BAYSHORE HIGHWAY, SUITE 400 BURLINGAME CA 94010
Business Address
Raifeld Pavel (Reporting) CIK: 0001813426 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-30319 | Film No.: 20928523